10x Genomics logo
10x Genomics TXG
$ 16.69 1.15%

Quarterly report 2024-Q3
added 10-29-2024

report update icon

10x Genomics Financial Statements 2011-2025 | TXG

Annual Financial Statements 10x Genomics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

5.64 B 5.98 B 8.99 B 18 B 3.66 B - 1.06 B - - - - - -

Shares

117 M 114 M 110 M 101 M 39.1 M - 82.9 M - - - - - -

Historical Prices

48.2 52.5 81.5 178 79.7 - - - - - - - -

Net Income

-255 M -166 M -58.2 M -543 M -31.3 M -112 M -18.8 M - - - - - -

Revenue

619 M 516 M 490 M 299 M 246 M 146 M 71.1 M - - - - - -

Cost of Revenue

209 M 120 M 74.1 M 58.5 M 61 M 28.7 M 10.6 M - - - - - -

Gross Profit

409 M 396 M 416 M 240 M 185 M 118 M 60.5 M - - - - - -

Operating Income

-265 M -168 M -52.3 M -534 M -30.6 M -111 M -18.4 M - - - - - -

Interest Expense

33 K 476 K 866 K 1.68 M 3.08 M 2.41 M 811 K - - - - - -

EBITDA

-230 M -143 M -31.1 M -520 M -23.5 M -44.5 M -14.1 M - - - - - -

Operating Expenses

675 M 564 M 469 M 775 M 215 M 166 M 78.9 M - - - - - -

General and Administrative Expenses

343 M 298 M 258 M 202 M 131 M - - - - - - - -

All numbers in USD currency

Quarterly Income Statement 10x Genomics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

121 M 120 M 119 M 118 M 117 M 116 M - - 114 M 113 M 113 M 111 M 110 M 109 M 108 M 101 M 99 M 96.8 M 96.2 M 29.2 M 15.6 M 14.8 M 14.5 M 13.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-35.8 M -37.9 M -59.9 M -93 M -62.4 M -50.7 M - - -64.5 M -42.4 M - -17.2 M -11.1 M -11.6 M - -65.8 M -40.2 M -21.1 M -7.13 M -9.6 M -10.9 M -3.64 M -75.5 M -15.3 M -5.92 M -15.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

152 M 153 M 141 M 154 M 147 M 134 M - - 115 M 114 M - 125 M 116 M 106 M - 71.8 M 42.9 M 71.9 M 75.3 M 61.2 M 55.8 M 53.6 M 50.6 M 36.6 M 31.7 M 27.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

45.3 M 48.9 M 48.1 M 58.1 M 47.2 M 35.9 M - - 27.7 M 25.5 M - 24.5 M 4.92 M 17.1 M - 14.4 M 10.1 M 15.1 M - 15.5 M 15 M 14 M - 5.24 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

106 M 104 M 92.9 M 95.5 M 99.6 M 98.4 M - - 86.9 M 89 M - 101 M 111 M 88.8 M - 57.4 M 32.9 M 56.8 M 58.7 M 45.7 M 40.8 M 39.6 M 35.7 M 31.4 M 27.2 M 23.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-41.5 M -41.7 M -61.5 M -94.8 M -63.4 M -52 M - - -63.1 M -41.7 M - -15.9 M -10.3 M -10.2 M - -65.3 M -39.4 M -19.9 M - -9.1 M -10.4 M -3.04 M - -14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

2.08 M -56 K 1 K -1.25 M -1.5 M 19 K - - 109 K 128 K - 219 K 209 K 221 K - 397 K 306 K 662 K - 708 K 695 K 684 K - 659 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -52.3 M - - -45.5 M - - -50.4 M -35.5 M - -15.9 M -687 K -5.46 M - -55.2 M -32.9 M -16.7 M - -4.88 M -8.18 M -2 M - -11.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

148 M 146 M 154 M 190 M 163 M 150 M - - 150 M 131 M - 117 M 121 M 99 M - 123 M 72.3 M 76.7 M - 54.8 M 51.2 M 42.6 M - 46.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

81.7 M 83 M 85.8 M 82.4 M 91.5 M 83.3 M - - 79.3 M 66.7 M - 62.1 M 68.7 M 56.9 M - 51.5 M 44.4 M 50.4 M - 32.6 M 32.6 M 26.9 M - 19.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements 10x Genomics TXG
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting 10x Genomics plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Health information services industry

Issuer Price % 24h Market Cap Country
Covetrus Covetrus
CVET
- - $ 2.94 B usaUSA
Cerner Corporation Cerner Corporation
CERN
- - $ 27.9 B usaUSA
Computer Programs and Systems Computer Programs and Systems
CPSI
- 4.4 % $ 133 M usaUSA
Accolade Accolade
ACCD
- 0.29 % $ 206 M usaUSA
iCAD iCAD
ICAD
- - $ 102 M usaUSA
Castlight Health, Inc. Castlight Health, Inc.
CSLT
- -7.28 % $ 227 M usaUSA
HMS Holdings Corp. HMS Holdings Corp.
HMSY
- - $ 3.29 B usaUSA
Inovalon Holdings, Inc. Inovalon Holdings, Inc.
INOV
- - $ 6.37 B usaUSA
Change Healthcare Change Healthcare
CHNG
- - $ 9.03 B usaUSA
MTBC MTBC
MTBC
- -0.58 % $ 51.7 M usaUSA
Evolent Health Evolent Health
EVH
$ 4.13 -0.72 % $ 387 M usaUSA
Health Catalyst Health Catalyst
HCAT
$ 2.38 1.28 % $ 143 M usaUSA
HealthStream HealthStream
HSTM
$ 23.83 -0.75 % $ 724 M usaUSA
OptimizeRx Corporation OptimizeRx Corporation
OPRX
$ 12.76 0.16 % $ 219 M usaUSA
Progyny Progyny
PGNY
$ 25.51 -0.23 % $ 2.19 B usaUSA
Premier Premier
PINC
$ 28.26 - $ 2.33 B usaUSA
Akerna Corp. Akerna Corp.
KERN
- - $ 161 M usaUSA
Phreesia Phreesia
PHR
$ 16.81 0.18 % $ 917 M usaUSA
HealthEquity HealthEquity
HQY
$ 92.45 -0.26 % $ 7.91 B usaUSA
American Well Corporation American Well Corporation
AMWL
$ 4.59 0.66 % $ 68.8 M usaUSA
Allscripts Healthcare Solutions Allscripts Healthcare Solutions
MDRX
- -10.39 % $ 886 M usaUSA
So-Young International So-Young International
SY
$ 2.8 -3.45 % $ 222 M chinaChina
GoodRx Holdings GoodRx Holdings
GDRX
$ 2.77 0.73 % $ 1.07 B usaUSA
R1 RCM R1 RCM
RCM
- - $ 3.81 B usaUSA
Omnicell Omnicell
OMCL
$ 45.78 0.46 % $ 2.11 B usaUSA
1Life Healthcare 1Life Healthcare
ONEM
- - $ 3.37 B usaUSA
Schrödinger Schrödinger
SDGR
$ 18.38 -2.29 % $ 1.34 B usaUSA
NantHealth NantHealth
NH
- -46.64 % $ 10.4 M usaUSA
NextGen Healthcare NextGen Healthcare
NXGN
- - $ 1.6 B usaUSA
Signify Health Signify Health
SGFY
- -0.02 % $ 7.21 B usaUSA
Zhongchao Zhongchao
ZCMD
$ 0.53 -1.34 % $ 2.76 M chinaChina
Streamline Health Solutions Streamline Health Solutions
STRM
- - $ 21.4 M usaUSA
Teladoc Health Teladoc Health
TDOC
$ 7.25 0.55 % $ 1.24 B usaUSA
Tabula Rasa HealthCare Tabula Rasa HealthCare
TRHC
- - $ 255 M usaUSA
Veeva Systems Veeva Systems
VEEV
$ 223.15 -0.49 % $ 35.8 B usaUSA
SCWorx Corp. SCWorx Corp.
WORX
$ 0.2 -1.6 % $ 292 K usaUSA